You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. VEIL (Vulnerability-reducing Engineered Infrared-obscurant Load)

    SBC: OCEANIT LABORATORIES INC            Topic: A13044

    Oceanit proposes to scale-up processes for low cost obscurant materials. These processes include the development , fabrication, and testing of materials and coatings.

    SBIR Phase II 2017 Department of DefenseArmy
  2. Mouse Stem Cell Research Using the Dracula Pipette

    SBC: GENESEARCH, INC.            Topic: 100

    Advanced approaches for genetic or epigenetic modification of embryonic stemEScellsincluding TALENZFNor CRISPR catalyzed genetic modifications or modulation of gene expression via small RNAssynthetic mRNAsor recombinant transcription factorshave revolutionized our ability to modify the cells from which novel mouse lines are producedIn contrastprocedures for utilizing these cells within the context ...

    STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  3. Stream Dx: accurate and efficient, point-of-care uroflometry for improved diagnosis, monitoring, and post-treatment evaluation of LUTS

    SBC: STREAM DX, INC            Topic: 300

    PROJECT SUMMARYABSTRACT Lower urinary tract symptomsLUTSis one of the most common medical problems among older menaffectingof men by the time they reachyears of age andby the time they reach the age ofLUTS is a progressive disease that has been shown to significantly increase the risk of depression and reduce quality of lifeDue to thisearly detection and active management of LUTS is criticalUroflo ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  4. Therapy Management System for Model-Based Behavioral Interventions

    SBC: Experiad LLC            Topic: 104

    In this Phase II SBIR applicationExperiad Solutions proposes to complete the development of Motivitya new type of software that has the potential to modernize the practice of behavioral therapy for autismApplied Behavior AnalysisABAis an evidence based autism treatment that is practiced by overBoard Certified Behavior AnalystsBCBAsin the USBCBAs analyze a child s unique needsthen construct an indi ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  5. ARF6 Inhibitors for Treatment of Acute Lung Injury

    SBC: NAVIGEN, INC.            Topic: NHLBI

    PROJECT SUMMARYAcute lung injuryALIand acute respiratory distress syndromeARDSresult from a common pathogenic processpulmonary injury or infection triggers an overwhelming inflammatory responsecytokine stormthat results in increased endothelial and epithelial permeability and efflux of inflammatory cellsproteinand water from the vascular system into the alveolar spaceThe further release of inflamm ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  6. Therapeutic D-peptide Inhibitor of HIV Entry

    SBC: NAVIGEN, INC.            Topic: R

    PROJECT SUMMARYWhile modern HIV combination therapy has transformed HIV into a manageable chronic infection for many patientsHIV AIDS remains a formidable global epidemicDespite the effectiveness of combining drugs from different classesside effects and drug resistance remain serious concerns for these life long therapiesThusthere is an enduring need for novel HIV inhibitors with new mechanisms of ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  7. Nutritional Therapy in Elderly with Heart Failure

    SBC: Essential Blends, LLC            Topic: NIA

    Project Summary Abstract We have developed a nutritional formulation of amino acids called UpBeat that is designed to promote physical function and quality of life in older individuals with heart failureReduced exercise capacity is a prominent clinical feature of heart failureThis leads to progressive muscle weakness and a vicious cycle of sedentary behaviorweight gainand subsequent development of ...

    STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  8. Development of an Open Speech Signal Processing Platform

    SBC: SensorLogic, Inc.            Topic: NIDCD

    This proposal will create an open speech signal processing platform. The open computational framework will be used for developing algorithms that will help accelerate acoustic and hearing science research. It will permit researchers to more rapidly and easily test new algorithms with greater control, performance, and ease. Several example systems will be created to show that the platform can be ad ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  9. Clinical Development of JS-K for the Treatment of Cancer

    SBC: JSK THERAPEUTICS INC.            Topic: 102

    PROJECT DESCRIPTIONJSK TherapeuticsJSKTDirect to Phase II Application Nitric oxideNOis a potentially powerful therapy against cancerSpontaneous NO generating drugs cannot be used to treat malignancies because of the pleiotropic effects of NOIn particularNO is a potent vasodilator with resultant hypotensionIn order to make NO based cancer therapy possibleit is necessary to develop agents that deliv ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  10. Development of technologies to advance fast and accurate tools for measuring fluorescence in living cells, with emphasis on developing assays optimized for screening in neuronal cells and brain tissue

    SBC: MONTANA MOLECULAR LLC            Topic: 105

    Project SummaryMontana Molecular is in the business of developing and marketing genetically encoded biosensors for academic research and drug discovery in living cellsOur biosensors provide robust detection of crucial second messenger signalingincluding DAGPIPcAMP and Caon both fluorescence microscopes and the large installed base of automated plate readerswith metrics that match or surpass those ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government